Drugs and biologicals
Ended Awarded
- Contract number
- HHSN26300085
- Awardee
-
Promega Corporation UEI MWM4N9L4S5X4
- Awarding agency
-
Office of the Director
National Institutes of Health, Department of Health and Human Services
- Obligated
- $3,626
Award facts
- Contract value 100% obligated
- $3,626.15 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- Not on record
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Madison, WI 53711, USA
Award details come from SAM.gov/FPDS.
About this award
Promega Corporation received a $3,626.15 firm fixed price BPA call award from the Office of the Director, a civilian federal agency, for drugs and biologicals on November 4, 2013, with an ultimate completion date of February 28, 2014. This contract was performed in Madison, Wisconsin, where Promega maintains its headquarters. The award utilized no small business set-aside designation, consistent with Promega's status as a large, capable contractor. This call order was placed against one of Promega's significant indefinite delivery vehicles—a $10 million Blanket Purchase Agreement with the National Institutes of Health's Office of Logistics and Acquisition Operations that covers biological materials, chemicals, medical and scientific equipment, and maintenance services.
As a global life sciences company specializing in biological research, diagnostic, and forensic products, Promega supplies advanced scientific technologies, laboratory reagents, and consumables to federal agencies across multiple sectors. The company's product portfolio includes DNA analysis systems, molecular diagnostic tools, nucleic acid extraction systems, and specialized research instruments that support critical scientific research and healthcare missions. Through its established federal relationships with agencies including the National Institutes of Health, Centers for Disease Control and Prevention, Food and Drug Administration, and Federal Bureau of Investigation, Promega has demonstrated consistent capability to meet complex government research and testing requirements through both prime contracts and task orders under larger acquisition vehicles.
Quick answers
Who was awarded contract HHSN26300085?
HHSN26300085 was awarded to Promega Corporation by Office of the Director (National Institutes of Health) on November 4, 2013.
How much is contract HHSN26300085 worth?
The government has obligated $3,626 on HHSN26300085.
Is contract HHSN26300085 an order under another contract?
Yes. HHSN26300085 is a BPA call under HHSN263199900051808B, a blanket purchase agreement.
Was contract HHSN26300085 competed?
The extent of competition for HHSN26300085 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award